tiprankstipranks
eFFECTOR Therapeutics (EFTR)
NASDAQ:EFTR

eFFECTOR Therapeutics (EFTR) Ownership - Who Owns eFFECTOR Therapeutics?

237 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 29, 2023Sold$365498
Aug 14, 2023
Stephen Worland
Ceo,director
Bought$17575

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$15290839

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,308,587Institution35.49%2,538,659
394,482Institution10.70%765,295
92,465Institution2.51%179,382
15,175Institution0.41%29,440
9,544Institution0.26%18,515
4,205Institution0.11%8,158

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
394,482Institution10.70%765,295
15,175Institution0.41%29,440
9,544Institution0.26%18,515
4,205Institution0.11%8,158

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
70,801Institution1.92%1,018,826
21,664Institution0.59%311,745

FAQ

Who Owns eFFECTOR Therapeutics (EFTR)?
Currently, no data Available
What percentage of eFFECTOR Therapeutics (EFTR) stock is held by institutional investors?
Currently, no data Available
What percentage of eFFECTOR Therapeutics (EFTR) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of eFFECTOR Therapeutics (EFTR)?
Stephen A. Schwarzman owns the most shares of eFFECTOR Therapeutics (EFTR).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis